Table 4.
Logistic regression of factors associated with achieved blood pressure control (<140/90 mm Hg) at baseline among Hispanic Systolic Blood Pressure Intervention Trial Participants
| Hispanics | Hispanics in Puerto Rico | US Mainland Hispanics | ||||
|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis (n=432) | Univariate analysis | Multivariate analysis (n=248) | Univariate analysis | Multivariate analysis(n=185) | |
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Social demographics | . | . | . | |||
| Age: 65–74 (vs <65) | 0.87 (0.65–1.16) | 0.84 (0.51–1.38) | 0.83 (0.57–1.21) | 0.96 (0.61–1.52) | 1.13 (0.52–2.43) | |
| Age: >75 (vs <65) | 0.59 (0.42–0.84) | 0.75 (0.43–1.31) | 0.57 (0.33–0.97) | 0.52 (0.32–0.84) | 0.74 (0.35–1.54) | |
| Male (vs female) | 1.47 (1.14–1.89) | 1.39 (0.91–2.13) | 1.46 (1.04–2.05) | 1.03 (0.55–1.9) | 1.23 (0.83–1.83) | |
| Lives with others (vs lives alone) | 1.24 (0.92–1.66) | 1.23 (0.82–1.86) | 1.34 (0.88–2.06) | |||
| <High school (vs high school graduate or higher) | 0.78 (0.58–1.05) | 1.09 (0.66–1.79) | 0.69 (0.45–1.07) | 1.07 (0.57–1.98) | 0.75 (0.5–1.14) | |
| Employed (vs not employed) | 1.43 (1.1–1.86) | 1.17 (0.69–1.97) | 1.49 (1.04–2.13) | 1.79 (0.89–3.61) | 1.3 (0.88–1.93) | |
| Has health insurance (vs no health insurance) | 0.81 (0.55–1.18) | 0.99 (0.49–2) | 0.92 (0.58–1.48) | |||
| Primary care provider (vs no primary care provider) | 1.11 (0.62–2) | 1.7 (0.76–3.83) | 0.58 (0.22–1.55) | |||
| CVD history (vs no CVD history) | 1.48 (1.07–2.05) | 1.81 (1.11–2.97) | 1.72 (1.08–2.76) | 3.81 (1.9–7.9) | 1.16 (0.74–1.82) | |
| Smoker (vs nonsmoker) | 1.12 (0.87–1.44) | 0.98 (0.69–1.39) | 1.12 (0.76–1.63) | |||
| Participates in physical activity (vs no physical activity) | 1.21 (0.94–1.56) | 1.19 (0.84–1.68) | 1.22 (0.83–1.8) | |||
| Clinical measures | . | . | . | |||
| No. of chronic diseases (unit increase) | 1.01 (0.93–1.1) | 1.05 (0.94–1.18) | 0.93 (0.83–1.05) | |||
| No. of BP medications <3 (vs ≥3) | 0.77 (0.57–1.04) | 0.66 (0.42–1.05) | 0.74 (0.48–1.13) | 0.87 (0.57–1.35) | ||
| Weight: BMI <25 (vs BMI ≥25) | 0.66 (0.47–0.94) | 0.62 (0.36–1.06) | 0.63 (0.39–1.02) | 0.56 (0.26–1.14) | 0.69 (0.41–1.16) | |
| eGFR (20 mL/min/1.73 m2[1 SD]) | 1 (0.99–1) | 1 (0.99–1.01) | 1 (0.99–1.01) | |||
| Study measures | . | . | . | |||
| General health status | 0.92 (0.8–1.06) | 0.83 (0.67–1.01) | 1.06 (0.77–1.48) | 0.93 (0.75–1.14) | ||
| EuroQol‐5D (health utility) | 0.78 (0.34–1.79) | 0.94 (0.28–3.18) | 0.79 (0.25–2.49) | |||
| Patient Health Questionnaire‐9 | 1.01 (0.98–1.04) | 1.01 (0.97–1.05) | 1 (0.96–1.04) | |||
| Patient satisfaction | 0.86 (0.74–1.01) | 0.97 (0.74–1.26) | 0.88 (0.72–1.08) | 0.85 (0.67–1.07) | ||
| Dementia screening | . | . | . | |||
| Logical memory I (0‐28) | 1.02 (1–1.05) | 0.99 (0.94–1.04) | 1.01 (0.98–1.04) | 1.05 (1.01–1.09) | 1.01 (0.92–1.1) | |
| Logical memory II (0‐14) | 1.02 (0.99–1.06) | 1 (0.96–1.05) | 1.06 (1–1.12) | 1.03 (0.91–1.17) | ||
| Montreal Cognitive Assessment | 1.02 (1–1.05) | 1 (0.93–1.08) | 1.02 (0.98–1.05) | 1.04 (1–1.08) | 1 (0.9–1.11) | |
| Digit Symbol Coding | 1 (0.99–1) | 1 (0.99–1) | 1.01 (1–1.02) | |||
| Functional assessment (Functional Activities Questionnaire) | 0.9 (0.86–0.95) | 0.9 (0.84–0.95) | 0.91 (0.85–0.98) | 0.92 (0.84–0.99) | 0.9 (0.83–0.98) | 0.91 (0.83–0.98) |
| Morisky Medication Adherence scale | 1.02 (0.93–1.12) | 1.06 (0.93–1.22) | 1.01 (0.87–1.17) | |||
Abbreviations: BP, blood pressure; BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; OR, odds ratio; SD, standard deviation.